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Main text  
Chronic respiratory symptoms are commonly reported by current and former cigarette smokers 
who lack spirometric evidence of COPD. These individuals are more likely to experience 
wheezing, breathlessness, limitation in exercise, chronic bronchitis, worse quality of life, 
exacerbations and more co-morbidities than heathy never-smokers (1-4) (Figure). The natural 
history, pathophysiology and management of smokers without evidence of COPD is poorly 
understood (3, 4). Smoking-induced airway diseases include chronic bronchitis, emphysema, 
and small airway disease, occurring either alone or in combination. These diseases also occur in 
smokers with asthma (3). Previous studies of inflammation, physiology and computed 
tomography (CT) imaging provides indirect evidence that small airway disease (<2 mm in 
diameter) contributes to respiratory symptoms in smokers with normal spirometry.  Cigarette 
smoking induces respiratory bronchiolitis of small airways before the development of 
emphysema (5, 6). The function of peripheral airways is abnormal in some smokers without 
COPD assessed by physiological techniques, such as multiple breath nitrogen washout (MBNW) 
(7) and impulse oscillometry (IOS) (8, 9). Analysis of expiratory and inspiratory computed 
tomography (CT) images detects increased nonemphysematous air trapping, a surrogate for 
functional small airways disease, in ever-smokers with normal spirometry (10-12). However, 
little is known about whether small airway dysfunction assessed by physiological tests, such as 
MBNW or IOS are worse in symptomatic smokers without COPD compared to asymptomatic 
smokers. In this issue of Respirology, Jetmalani et al (13) report the results of a prospective, 
observational study designed to determine the prevalence of respiratory symptoms (chronic 
bronchitis, dyspnoea, wheeze) and small airway dysfunction and their interrelationship in 
eighty young to middle-aged current and former smokers without spirometric COPD. Small 
airway dysfunction was assessed by measuring ventilation heterogeneity in diffusion-
dependent (Sacin) and convection-dependent (Scond) airways by MBNW and by measuring 
respiratory resistance at 5 (R5) and 20 (R20) Hz and reactance at 5 (X5) Hz by IOS.  
 
An important finding of the study was that abnormalities in either MBNW (predominantly Sacin) 
or IOS (predominantly R5) were found in three quarters of current and former smokers without 
spirometric COPD. Half the subjects had an abnormal MDNW or IOS measurement, and in one 
quarter there was an overlap in abnormal IOS and MBNW variables. The results of the study 
and those from previous studies using physiological tests (7-9) and CT imaging biomarkers (10-
12) demonstrate that small airway dysfunction is commonly found in this group of current and 
former smokers. Interestingly, smokers without spirometric COPD following smoking cessation 
show sustained improvements of conductive airway dysfunction (Scond), but not in acinar airway 
function (Sacin) suggesting that some abnormalities of small airway disease are reversible, 
possibly due to reduced inflammation or hypersecretion (14).   
 
Of interest, Jetmalani et al (13) found that 68% of the young to middle-aged smokers without 
COPD reported at least one respiratory symptom (chronic bronchitis 39%, dyspnoea at rest or 
on exertion 38%, and episodic wheeze 49%). The prevalence rate of respiratory related 
impairment is slightly higher than that reported in the SPIROMICS (50%)(1) and COPDGene 
(54%) (2) cohorts of older smokers with normal spirometry. Jetmalani et al (13) found that 
symptoms of chronic bronchitis related to peripheral conductive airway function (Scond), while 
wheeze was related to measures of large airway function (R5 and spirometry). Nevertheless, 
the difference in abnormalities between symptomatic and asymptomatic subjects was relatively 
small. Previous studies in older smokers with normal spirometry have reported that CT air 
trapping is associated with worse clinical outcomes (12) and lung function decline (10), whereas 
CT airway wall thickness is associated with symptoms of chronic bronchitis (1).   
 
Although important, the study by Jetmalani et al (13) has some limitations. The symptoms 
questionnaire did not provide information on exacerbations or quality of life of the participants 
to determine if these clinical outcomes related to physiological tests of small airway 
dysfunction. Information on a history of current asthma or previous asthma is lacking despite 
half of the young and middle-aged smokers reporting episodic wheeze. Smokers with asthma 
without spirometric COPD experience clinical features that overlap with symptomatic current 
and former smokers with normal spirometry (3), including small airway dysfunction (15). It is 
not stated whether the participants received treatment with inhaled bronchodilators or inhaled 
corticosteroids, which might have influenced measures of small airway function. As the authors 
acknowledge, it would have been informative if CT imaging had been included for comparison 
with MBNW and IOS measures. 
 
What are the implications of the study by Jetmalani et al (13) for future  research in smokers 
without spirometric COPD? The findings when taken together with previous research show that 
a considerable proportion of smokers and former smokers have abnormal small airway function 
and that certain measures of small airway dysfunction correlate with specific respiratory 
symptoms. Nevertheless, the role of small airway dysfunction in causing respiratory symptoms 
and impairment is not established. The investigation of research questions arising from these 
findings will require large long-term studies. For example, do physiological and imaging 
biomarkers of small airway disease in smokers without COPD have variable relationships with 
different respiratory symptom? Do factors, such as heterogeneity in phenotypes of smoking-
induced airway diseases, age or intensity of smoking history influence relationships between 
symptoms and small airway dysfunction? Do physiological tests, such as IOS and MBNW 
identify smokers with normal spirometry who are at risk of developing COPD and do these 
measures relate to imaging-based biomarkers? Importantly, is the assessment of small airway 
function in symptomatic smokers useful in predicting benefits from different treatments? 
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Figure legend 
 
Figure 1: Clinical outcomes and mechanisms of airway disease in current and former smokers 
without spirometric evidence of COPD (FEV1/FVC ratio >0.7)  
*: It is not known whether current and former smokers with smoking-induced airway disease 
without spirometric evidence of COPD or a history of asthma demonstrate corticosteroid 
insensitivity or have pathological features of ‘asthma-associated’ airway remodelling 
 
 
